$100B Market Impact.** Automating pharma compliance to capture a $20B TAM. A 2M context provides a competitive edge.
**$100B Market Impact:** Transforming 12 months of manual review into minutes of autonomous intelligence.
**Enterprise-Ready Interface.** Secure, scalable access for biotech and legal teams to manage regulatory intelligence.
**Secure Enterprise Portal.** Professional login system designed for high-security medical-legal environments.
**One-Click Upload.** Ingesting 500+ page protocols for rapid autonomous analysis.
**Multi-Type Data Support.** Advanced parsing for clinical protocols and regulatory files with zero data loss.
**High-Speed Ingestion.** Processing heavy clinical PDFs in seconds using Gemini's 2M token context window.
**Agentic Workflow Architecture.** Multi-agent orchestration using LangGraph and Gemini for autonomous, traceable reasoning.
**Start Analysis.** Initiating autonomous risk detection for 500+ page clinical trial protocols.
**Targeted AI Analysis:** Selecting specific regulatory frameworks like FDA/EMA for precise, autonomous risk assessment.
**System Performance Tracking:** Real-time monitoring of autonomous reasoning tasks and execution speed.
**Audit-Ready Insights:** Automated summary detecting critical review areas and compliance enhancement recommendations.
**Compliance Intelligence Dashboard:** Real-time scoring, automated risk flagging, and executive summaries for clinical trials.
**Actionable Risk Analysis:** Detailed compliance flagging with precise document locations and automated remediation steps.
**Deep Compliance Intelligence:** Autonomous detection of missing clinical disclosures with specific remediation advice.
**Audit-Ready Exports:** Generating professional compliance reports tailored for FDA, EMA, and ICH global standards.
**Final Audit Report:** Complete executive summary and report metadata generated by multi-agent reasoning.

OMNY-ANALYST: Autonomous Regulatory Intelligence for Biotech

"Transforming 500+ page clinical protocols into audit-ready decisions in minutes — not months."

BUSINESS IMPACT

The Problem: Clinical trials are delayed by 12 months due to manual review.
The Cost: Companies lose billions in potential revenue.
The Solution: OMNI-ANALYST automates the $100B bottleneck of medical-legal compliance.

CORE CAPABILITIES

Gemini 2.0 Power: Ingests 500+ page protocols in one step (2M token context).
Agentic Reasoning: Multi-agent system that reasons like a regulatory expert.
Zero-Error Focus: Automated risk flagging with Audit-Ready reports.